Replies to post #390228 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

My GUESS is it’s an FDA delay. I know they have a goal of 10 months for 90 % of ANDA’s but it’s only been few days since the 10 month mark passed. I also would GUESS a small market product like an extended release dopamine agonist would not be a priority for the FDA.